重症急性胰腺炎患者ICU期间下肢深静脉血栓形成的发生率和危险因素分析

程家浩; 刘正东

doi:10.13201/j.issn.1009-5918.2021.09.006

重症急性胰腺炎患者ICU期间下肢深静脉血栓形成的发生率和危险因素分析

程家浩,
刘正东^,

- 安徽医科大学附属六安医院(六安市人民医院)重症医学科(安徽六安,237005)

详细信息

通讯作者: 刘正东,E-mail:LZDYS@126.com

中图分类号: R657.51

收稿日期: 2021-05-18

Incidence and risk factors of lower extremity deep venous thrombosis in severe acute pancreatitis patients during intensive care unit period

CHENG Jiahao,
LIU Zhengdong^,

- Department of Intensive Care Unit, the Affiliated Lu'an Hospital, Anhui Medical University, the Lu'an People's Hospital, Lu'an, Anhui, 237005, China

More Information

Corresponding author: LIU Zhengdong, E-mail: LZDYS@126.com

Received Date: 18 May 2021

摘要

摘要: 目的:探讨重症急性胰腺炎(SAP)患者ICU期间下肢深静脉血栓的发生率和危险因素。方法:回顾2017年1月-2020年10月期间发病72 h内收住于安徽医科大学附属六安医院ICU的117例SAP患者,收集患者性别、年龄、体重指数(BMI),转入时血脂、血糖、血小板、D-二聚体以及ICU期间是否发生腹腔内高压(IAH)和序贯器官衰竭评分(SOFA)等。根据其在ICU期间是否发生下肢深静脉血栓分为血栓组与非血栓组,采用单因素分析比较两组患者临床资料的差异,采用多因素Logistic回归分析筛选患者发生下肢深静脉血栓的独立危险因素,并采用受试者工作特征曲线(ROC)评估各独立危险因素的预测价值。结果:117例患者中共有33例(28.20%)发生下肢深静脉血栓,84例未发生血栓。单因素分析显示,血栓组与非血栓组在入院时BMI,血脂,D-二聚体水平,以及ICU期间发生IAH,股静脉置管,SOFA评分差异均有统计学意义(P<0.05)。多因素Logistic回归分析显示BMI,IAH,SOFA评分为患者发生下肢深静脉血栓的独立危险因素(OR=1.345,95%CI:1.040~1.739,P=0.024;OR=5.440,95%CI:1.444~20.497,P=0.012;OR=1.718,95%CI:1.176~2.510,P=0.005)。ROC曲线显示3项独立危险因素联合预测下肢深静脉血栓发生的曲线下面积为0.871(P<0.001),敏感度为78.79%,特异度为84.52%。结论:高体重指数、腹腔内高压、高SOFA评分是SAP患者形成下肢深静脉血栓的高危因素,在这种严重炎症性疾病背景下,下肢深静脉血栓的预防可能是不充分的。
- 重症急性胰腺炎 /
- 腹腔内高压 /
- 序贯器官衰竭评分 /
- 下肢深静脉血栓 /
- 危险因素
Abstract: Objective: To explore the incidence rate and risk factors affecting the occurrence of lower extremity deep venous thrombosis in patients with severe acute pancreatitis during intensive care unit period.Methods: A total of 117 patients with severe acute pancreatitis within 72 hours of onset admitted to the ICU of Lu'an Hospital Affiliated to Anhui Medical University from January 2017 to October 2020 were enrolled. The clinical data were collected, including gender, age, body mass index(BMI), blood fat, blood glucose, platelets, D-dimer at the time of transfer, the occurence of intra-abdominal hypertension(IAH) or not, Sequential Orginal Failure assessment(SOFA) scores during ICU period, and so on. According to occurrence of lower extremity deep venous thrombosis or not, these patients were divided into thrombosis group and non-thrombosis group. Univariate analysis was used to compare the differences in clinical data between the two groups. Multivariate Logistic regression analysis was used to screen the independent risk factors for lower extremity deep vein thrombosis, and the predictive efficacy was evaluated by receiver operating characteristic(ROC) curve.Results: Thirty-three patients(28.20%) were diagnosed as having lower extremity deep venous thrombosis. There were statistical differences between two groups in BMI, blood fat, D-dimer levels at admission, the incidence of IAH, femoral vein catheterization rate and SOFA score during ICU period(P<0.05).Resultsof multivariate Logistic regression analysis showed that BMI, IAH, and SOFA score during ICU period were independent risk factors for lower extremity deep venous thrombosis(OR=1.345, 95%CI: 1.040-1.739, P=0.024; OR=5.440, 95%CI: 1.444-20.497, P=0.012; OR=1.718, 95%CI: 1.176-2.510, P=0.005). ROC curve showed the area under the curve by combining these three factors was 0.871(P<0.001), with sensitivity of 78.79% and specificity of 84.52%.Conclusion: High body mass index, intra-abdominal hypertension and high SOFA score are high risk factors for the formation of lower extremity deep vein thrombosis in severe acute pancreatitis patients.The prevention of lower extremity deep vein thrombosis may be inadequate in the context of this severe inflammatory disease.
- severe acute pancreatitis /
- intra-abdominal hypertension /
- sequential organ failure assessment /
- lower extremity deep venous thrombosis /
- risk factor

HTML全文

参考文献(20)

[1]	Petrov MS,Yadav D.Global epidemiology and holistic prevention of pancreatitis[J].Nat Rev Gastroenterol Hepatol,2019,16(3):175-184.
[2]	Zhou H,Mei X,He X,et al.Severity stratification and prognostic prediction of patients with acute pancreatitis at early phase:A retrospective study[J].Medicine(Baltimore),2019,98(16):e15275.
[3]	Chung WS,Lin CL.Association between venous thromboembolism and acute pancreatitis:An analysis from the nationwide inpatient sample[J].Clin Respir J,2020,14(4):320-327.
[4]	Dumnicka P,Maduzia D,Ceranowicz P,et al.The Interplay between Inflammation,Coagulation and Endothelial Injury in the Early Phase of Acute Pancreatitis:Clinical Implications[J].Int J Mol Sci,2017,18(2):354.
[5]	Ahmad DS,Mansoor E,Alikhan MM,et al.Risk of Venous Thromboembolism in Acute Necrotizing Pancreatitis:A Large Database Study[J].Pancreas,2021,50(1):71-76.
[6]	Trikudanathan G,Umapathy C,Munigala S,et al.Venous Thromboembolism Is Associated With Adverse Outcomes in Hospitalized Patients With Acute Pancreatitis:A Population-Based Cohort Study[J].Pancreas,2017,46(9):1165-1172.
[7]	Darzi AJ,Karam SG,Charide R,et al.Prognostic factors for VTE and bleeding in hospitalized medical patients:a systematic review and meta-analysis[J].Blood,2020,135(20):1788-1810.
[8]	Banks PA,Bollen TL,Dervenis C,et al.Classification of acute pancreatitis——2012:revision of the Atlanta classification and definitions by international consensus[J].Gut,2013,62(1):102-11.
[9]	Kearon C,Akl EA,Ornelas J,et al.Antithrombotic Therapy for VTE Disease:CHEST Guideline and Expert Panel Report[J].Chest,2016,149(2):315-352.
[10]	李晓强,张福先,王深明.深静脉血栓形成的诊断和治疗指南(第三版)[J].中国血管外科杂志(电子版),2017,9(4):250-257.
[11]	Kirkpatrick AW,Roberts DJ,De Waele J,et al.Intra-abdominal hypertension and the abdominal compartment syndrome:updated consensus definitions and clinical practice guidelines from the World Society of the Abdominal Compartment Syndrome[J].Intensive Care Med,2013,39(7):1190-1206.
[12]	Maraví Poma E,Zubia Olascoaga F,Petrov MS,et al.SEMICYUC 2012.Recommendations for intensive care management of acute pancreatitis[J].Med Intensiva,2013,37(3):163-179.
[13]	Roch AM,Maatman TK,Carr RA,et al.Venous Thromboembolism in Necrotizing Pancreatitis:an Underappreciated Risk[J].J Gastrointest Surg,2019,23(12):2430-2438.
[14]	Maatman TK,McGuire SP,Lewellen KA,et al.Prospective Analysis of the Mechanisms Underlying Ineffective Deep Vein Thrombosis Prophylaxis in Necrotizing Pancreatitis[J].J Am Coll Surg,2021,232(1):91-100.
[15]	Smit M,Buddingh KT,Bosma B,et al.Abdominal Compartment Syndrome and Intra-abdominal Ischemia in Patients with Severe Acute Pancreatitis[J].World J Surg,2016,40(6):1454-1461.
[16]	Zhou J,Ke L,Tong Z,et al.Risk factors and outcome of splanchnic venous thrombosis in patients with necrotizing acute pancreatitis[J].Thromb Res,2015,135(1):68-72.
[17]	刘伟,刘盛楠,王子晨.重症急性胰腺炎患者并发腹内高压或腹腔间隔室综合征的治疗及其效果观察[J].临床急诊杂志,2020,21(11):896-899,904.
[18]	Singer GA,Riggi G,Karcutskie CA,et al.Anti-Xa-guided enoxaparin thromboprophylaxis reduces rate of deep venous thromboembolism in high-risk trauma patients[J].J Trauma Acute Care Surg,2016,81(6):1101-1108.
[19]	Malinoski D,Jafari F,Ewing T,et al.Standard prophylactic enoxaparin dosing leads to inadequate anti-Xa levels and increased deep venous thrombosis rates in critically ill trauma and surgical patients[J].J Trauma,2010,68(4):874-880.
[20]	Ko A,Harada MY,Barmparas G,et al.Association Between Enoxaparin Dosage Adjusted by Anti-Factor Xa Trough Level and Clinically Evident Venous Thromboembolism After Trauma[J].JAMA Surg,2016,151(11):1006-1013.